DOI: 10.1093/joneph/aajag254 ISSN: 1121-8428

Post-Nephrectomy Renal Outcomes in Living Kidney Donors with Diabetes and Prediabetes: A Retrospective Cohort Study

Saifu Yin, Yan Zhou, Wenxia Huang, Xia Huang, Yun Luo, Xing Li, Lijuan Wu, Turun Song, Tao Lin

Abstract

Background

Kidney transplantation is the optimal treatment for end-stage renal disease (ESRD), but the persistent donor shortage necessitates expanding the donor pool, including utilizing living donors with dysglycemia. However, their post-nephrectomy safety remains inadequately characterized.

Methods

This retrospective cohort study analyzed 771 living donors (699 normal, 53 impaired fasting glucose [IFG], 19 diabetes) undergoing nephrectomy (2017-2023). The primary outcome was acute eGFR slope. Multivariable linear regression identified independent risk factors. A targeted systematic review with meta-analysis was conducted to summarize existing evidence.

Results

Over a median 31-month follow-up, no donors developed ESRD. Diabetic donors had a higher incidence of eGFR <45 ml/min/1.73 m2 (10.5% vs. 1.9% vs. 1.4%, P=0.041). The acute eGFR slope was steeper in diabetic donors (-17.3 vs. -14.4 vs. -13.2 ml/min/1.73m2/year, P=0.038). Multivariable analyses identified diabetes (β=-3.85, 95%CI: -7.24--0.47, P=0.026), hypertension, microalbuminuria, and higher body mass index as independent risk factors. An exploratory subgroup analysis showed that IFG donors with baseline eGFR <90 mL/min/1.73m2 had a steeper eGFR slope compared to those with eGFR ≥90 ml/min/1.73m2 (P=0.004). Additional meta-analyses suggested that donors with dysglycemia may have worse renal function (P=0.036) and a higher incidence of hypertension (P=0.031) with high heterogeneity.

Conclusion

Pre-donation diabetes may increase post-nephrectomy renal risk, while IFG alone may be safe unless accompanied by reduced baseline eGFR. Notably, these hypothesis-generating findings are limited by the small sample size of the diabetic and IFG groups, and relatively short follow-up. Large multicenter cohorts with decades-long follow-up are still required.